SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Clarification sought from Sequent Scientific

27 Jul 2015 Evaluate

Sequent Scientific has informed that they referred to the news item in Economic Times on July 27, 2015 titled Sequent Unit set to buy Mumbai based Lykas veterinary business. Sequent has a stated strategic intent of creating a global powerhouse in animal health business through its subsidiary Alivira Animal Health Ltd. Towards this objective, the Company continues to explore and evaluate strategic growth opportunities, including inorganic opportunities. Whenever, there is any event or information that will have a significant bearing on the performance of the Company or any price-sensitive event, they will promptly inform the stock exchanges. Company has nothing specific to report at this point of time.

The above information is a part of company’s filings submitted to BSE.

Viyash Scientific Share Price

208.90 0.05 (0.02%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×